• 

  Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.

  Gallery

  Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.

  Evidence, MammaPrint, Other, Validation

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.

PUBLICATION: Transl Oncol. 2019 Sep 9;12(12):1557-1565. doi: 10.1016/j.tranon.2019.08.008. AUTHORS: Slembrouck Read More

kevin2024-03-25T08:36:04-04:00September 9th, 2019|Evidence, MammaPrint, Other, Validation|

Read More

• 

  MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology

  Gallery

  MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology

  BluePrint, Evidence, MammaPrint, Other, Validation

MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology

PUBLICATION: Journal of Molecular Diagnostics September 2019 Volume 21, Issue Read More

kevin2024-03-25T08:36:57-04:00September 1st, 2019|BluePrint, Evidence, MammaPrint, Other, Validation|

Read More

• 

  Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

  Gallery

  Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

  Adjuvant, Evidence, MINDACT

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

PUBLICATION: Journal of Clinical Oncology 37, no. 22 (August 01, Read More

kevin2024-03-25T08:47:41-04:00August 1st, 2019|Adjuvant, Evidence, MINDACT|

Read More

• 

  Copy Number Profiling of MammaPrint Genes Reveals Association with the Prognosis of Breast Cancer Patients

  Gallery

  Copy Number Profiling of MammaPrint Genes Reveals Association with the Prognosis of Breast Cancer Patients

  BluePrint, Evidence, MammaPrint, Other, Validation

Copy Number Profiling of MammaPrint Genes Reveals Association with the Prognosis of Breast Cancer Patients

PUBLICATION: J Breast Cancer. 2017 Sep;20(3):246-253. English. Published online Sep Read More

kevin2024-03-25T09:00:19-04:00September 22nd, 2017|BluePrint, Evidence, MammaPrint, Other, Validation|

Read More

• 

  A Breast Cancer Gene Signature for Indolent Disease

  Gallery

  A Breast Cancer Gene Signature for Indolent Disease

  Adjuvant, Evidence, MammaPrint, RASTER

A Breast Cancer Gene Signature for Indolent Disease

PUBLICATION: Breast Cancer Res Treat. 2017 Oct;117(3):483-95. doi: 10.1007/s10549-008-0191-2. Epub Read More

kevin2024-03-25T09:05:40-04:00July 1st, 2017|Adjuvant, Evidence, MammaPrint, RASTER|

Read More

• 

  Breast Cancer: Determining the Genetic Profile from Ultrasound-Guided Percutaneous Biopsy Specimens Obtained During Diagnostic Workups

  Gallery

  Breast Cancer: Determining the Genetic Profile from Ultrasound-Guided Percutaneous Biopsy Specimens Obtained During Diagnostic Workups

  Evidence, MammaPrint, Other

Breast Cancer: Determining the Genetic Profile from Ultrasound-Guided Percutaneous Biopsy Specimens Obtained During Diagnostic Workups

PUBLICATION: Radiología (English Edition) Volume 58, Issue 3, May–June 2016, Read More

kevin2024-03-25T09:20:15-04:00June 14th, 2016|Evidence, MammaPrint, Other|

Read More

• 

  Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

  Gallery

  Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

  Evidence, MammaPrint, Other, Validation

Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

PUBLICATION: Breast Cancer Res Treat (2016) 156: 279. https://doi.org/10.1007/s10549-016-3764-5 AUTHORS: Read More

kevin2024-03-25T09:21:49-04:00March 22nd, 2016|Evidence, MammaPrint, Other, Validation|

Read More

• 

  MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

  Gallery

  MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

  Evidence, MammaPrint, Other, Validation

MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

PUBLICATION: J Mol Diagn. 2014 Mar;16(2):190-7. doi: 10.1016/j.jmoldx.2013.10.008. Epub 2013 Read More

kevin2024-03-25T10:23:52-04:00March 1st, 2014|Evidence, MammaPrint, Other, Validation|

Read More

• MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience

  MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience

  Evidence, MammaPrint, Other

MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience

PUBLICATION: Scientifica (Cairo). 2012; 2012: 942507. Published online 2012 Dec Read More

kevin2024-03-25T10:48:40-04:00December 31st, 2012|Evidence, MammaPrint, Other|

Read More

• The EORTC 10041/BIG 03-04 MINDACT Trial is Feasible: Results of the Pilot Phase

  The EORTC 10041/BIG 03-04 MINDACT Trial is Feasible: Results of the Pilot Phase

  Adjuvant, Evidence, MammaPrint, MINDACT

The EORTC 10041/BIG 03-04 MINDACT Trial is Feasible: Results of the Pilot Phase

PUBLICATION: European Journal of Cancer, December 2011, Volume 47, Issue Read More

kevin2024-03-07T11:48:20-05:00December 1st, 2011|Adjuvant, Evidence, MammaPrint, MINDACT|

Read More